NICOLE STAMER: Open Payments
NPI 1295257954 · IOWA CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| ABBVIE INC. | 2 | $39 |
| Celltrion USA Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $33 |
| Intercept Pharmaceuticals, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $17 |
| Madrigal Pharmaceuticals | 1 | $16 |
| QOL Medical, LLC | 1 | $14 |
| GENZYME CORPORATION | 1 | $14 |
Products named: XIFAXAN, ENTYVIO, VEGZELMA, OMVOH, RINVOQ, OCALIVA, EOHILIA, IBSRELA.
Industry payments across IA — which companies pay providers there.
